Study Finds Psilocybin Anti-Depression Effects Last at Least One Year
A year after a Johns Hopkins psilocybin-assisted therapy study, researchers find the number of people who benefited from receiving two doses actually increased.
johns hopkins
Can Psychedelics Treat Alzheimer’s Disease?
Since substances such as LSD and psilocybin have powerful anti-inflammatory properties, researchers argue that the microbiological action of psychedelics may therefore help fight brain-based symptoms in early Alzheimer’s patients.
Why Psychedelic Research May Bring the Next Big Breakthrough in Dementia Treatment
“Psychedelics are well-observed to basically rewire the brain,” says Return Health CEO Dr. James Kuo, who is currently working with DMT because it’s shown the most efficacy in neurogenesis.
Psilocybin Study for Tobacco Addiction Receives First Federal Psychedelics Research Grant in 50 Years
A Johns Hopkins Medicine professor says “it was only a matter of time,” while lead researcher calls the historic grant “monumental” for the psychedelics movement.
End of content
End of content